Viola Bronsema

Dr. Viola Bronsema

CEO, BIO Deutschland

Dr Viola Bronsema has been Secretary General and CEO of BIO Deutschland, Germany’s Biotechnology Industry Association, since 2006. With its allmost 400 corporate members, the sector association represents Germany’s innovative biotechnology enterprises and corporations. Viola is member of the Board of Directors with Curevac SE and NV since August 2020 and member of Council on Technological Sovereignty of the Federal Research Ministry.
Previously, Viola was Head of Communications of Roche Diagnostics GmbH and of Roche Diagnostics Europe, Middle East, Africa. Parallel to that function she was Managing Director of the public private partnership Stadtmarketing Mannheim GmbH, in an honorary appointment for several years. From 2000 to 2002, she was spokeswoman and head of press and public relations at Lilly Pharma Holding GmbH.
Viola earned her Ph.D. at the Centre for Molecular Biology (ZMBH) at the University of Heidelberg, Germany, where she did research on hepatitis B-viruses and also bacterial pathogens before she started training to become a Public Relations specialist in 1995. Her carrier in communications started at a health care consultancy in Frankfurt am Main where she was a Senior Consultant working i. e. with Genentech and Serono. After that she worked as editor and spokesperson in the press office of the German Cancer Research Center (DKFZ).

www.linkedin.com/in/viola-bronsema-aa899816/

“Our biotech start-ups are and will remain the key driver for innovation – we need them for a healthy ecosystem that spans the entire value-added chain. Let’s work on making bioscience-based entrepreneurship more attractive in Germany”

save